Zimmermann, Stefan

Scientific Advances in Lung Cancer 2015

Tsao, A. S., Scagliotti, G. V., Bunn, P. A., Carbone, D. P., Warren, G. W., Bai, C., de Koning, H. J., Yousaf-Khan, A. U., McWilliams, A., Tsao, M. S., et al. (2016) · Journal of Thoracic Oncology

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 284

Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: Comparative pharmacokinetics and drug–drug interactions

Peters, S., Zimmermann, S., & Adjei, A. A. (2014) · Cancer Treatment Reviews

Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research

Cited by 155

Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases

Zimmermann, S., Dziadziuszko, R., & Peters, S. (2014) · Cancer Treatment Reviews

Brain Metastases and TreatmentLung Cancer Treatments and Mutations

Cited by 147

A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy

Horisberger, A., La Rosa, S., Zurcher, J.-P., Zimmermann, S., Spertini, F., Coukos, G., & Obeid, M. (2018) · Journal for ImmunoTherapy of Cancer

Cancer Immunotherapy and BiomarkersOral health in cancer treatment

Cited by 81